Form 8-K - Current report:
SEC Accession No. 0001493152-24-030764
Filing Date
2024-08-08
Accepted
2024-08-08 16:07:11
Documents
62
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43850
2 ex99-1.htm EX-99.1 68829
3 ex99-2.htm EX-99.2 32859
4 ex99-3.htm EX-99.3 12919
5 ex99-1_001.jpg GRAPHIC 14290
6 ex99-2_001.jpg GRAPHIC 194902
7 ex99-2_002.jpg GRAPHIC 611303
8 ex99-2_003.jpg GRAPHIC 350301
9 ex99-2_004.jpg GRAPHIC 233388
10 ex99-2_005.jpg GRAPHIC 290925
11 ex99-2_006.jpg GRAPHIC 262730
12 ex99-2_007.jpg GRAPHIC 302907
13 ex99-2_008.jpg GRAPHIC 259403
14 ex99-2_009.jpg GRAPHIC 308283
15 ex99-2_010.jpg GRAPHIC 328509
16 ex99-2_011.jpg GRAPHIC 261338
17 ex99-2_012.jpg GRAPHIC 304720
18 ex99-2_013.jpg GRAPHIC 287941
19 ex99-2_014.jpg GRAPHIC 335677
20 ex99-2_015.jpg GRAPHIC 208968
21 ex99-2_016.jpg GRAPHIC 200981
22 ex99-2_017.jpg GRAPHIC 208477
23 ex99-2_018.jpg GRAPHIC 342212
24 ex99-2_019.jpg GRAPHIC 241912
25 ex99-2_020.jpg GRAPHIC 432020
26 ex99-2_021.jpg GRAPHIC 338147
27 ex99-2_022.jpg GRAPHIC 289707
28 ex99-2_023.jpg GRAPHIC 61837
29 ex99-2_024.jpg GRAPHIC 234214
30 ex99-2_025.jpg GRAPHIC 405743
31 ex99-2_026.jpg GRAPHIC 393214
32 ex99-2_027.jpg GRAPHIC 374436
33 ex99-2_028.jpg GRAPHIC 318850
34 ex99-2_029.jpg GRAPHIC 132908
35 ex99-3_001.jpg GRAPHIC 1057987
36 ex99-3_002.jpg GRAPHIC 1972754
37 ex99-3_003.jpg GRAPHIC 797290
38 ex99-3_004.jpg GRAPHIC 994384
39 ex99-3_005.jpg GRAPHIC 904743
40 ex99-3_006.jpg GRAPHIC 1156576
41 ex99-3_007.jpg GRAPHIC 757198
42 ex99-3_008.jpg GRAPHIC 716710
43 ex99-3_009.jpg GRAPHIC 676121
44 ex99-3_010.jpg GRAPHIC 1124024
45 ex99-3_011.jpg GRAPHIC 773015
46 ex99-3_012.jpg GRAPHIC 1366552
47 ex99-3_013.jpg GRAPHIC 1075269
48 ex99-3_014.jpg GRAPHIC 915000
49 ex99-3_015.jpg GRAPHIC 240528
50 ex99-3_016.jpg GRAPHIC 730521
  Complete submission text file 0001493152-24-030764.txt   32378114

Data Files

Seq Description Document Type Size
51 XBRL SCHEMA FILE ltrn-20240808.xsd EX-101.SCH 3030
52 XBRL LABEL FILE ltrn-20240808_lab.xml EX-101.LAB 34240
53 XBRL PRESENTATION FILE ltrn-20240808_pre.xml EX-101.PRE 22369
64 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3793
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 241188262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)